Membrane actions of 1α,25(OH)2D3 are mediated by Ca2+/calmodulin-dependent protein kinase II in bone and cartilage cells

• Published in: The Journal of steroid biochemistry and molecular biology Vol. 145; pp. 65 - 74
• Main Authors: Doroudi, Maryam, Plaisance, Marc C., Boyan, Barbara D., Schwartz, Zvi
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01-01-2015
• Subjects: Calmodulin; CaMKII; Chondrocytes; Osteoblasts; Pdia3; Vitamin D; AA; Pdia3; PGE2; CaMKII; Vitamin D; Chondrocytes; PLA2; PLAA; PKC; Osteoblasts; CaM; Calmodulin
• ISSN: 0960-0760; 1879-1220
• DOI: 10.1016/j.jsbmb.2014.09.019

•1α,25(OH)2D3-dependent CaMKII activation requires Pdia3, PLAA, Cav-1 and caveolae.•CaMKII and CaM mediate signaling from 1α,25(OH)2D3-Pdia3 complexes to PLA2.•1α,25(OH)2D3 stimulates the interactions between PLAA and CaM.
1α,25(OH)2D3 regulates osteoblasts and chondrocytes via its membrane-associated receptor, protein disulfide isomerase A3 (Pdia3) in caveolae. 1α,25(OH)2D3 binding to Pdia3 leads to phospholipase-A2 (PLA2)-activating protein (PLAA) activation, stimulating cytosolic PLA2 and resulting in prostaglandin E2 (PGE2) release and PKCα activation, subsequently stimulating differentiation. However, how PLAA transmits the signal to cPLA2 is unknown. Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) activation is required for PLA2 activation in vascular smooth muscle cells, suggesting a similar role in 1α,25(OH)2D3-dependent signaling. The aim of the present study is to evaluate the roles of CaM and CaMKII as mediators of 1α,25(OH)2D3-stimulated PLAA-dependent activation of cPLA2 and PKCα, and downstream biological effects. The results indicated that 1α,25(OH)2D3 and PLAA-peptide increased CaMKII activity within 9min. Silencing Cav-1, Pdia3 or Plaa in osteoblasts suppressed this effect. Similarly, antibodies against Plaa or Pdia3 blocked 1α,25(OH)2D3-dependent CaMKII. Caveolae disruption abolished activation of CaMKII by 1α,25(OH)2D3 or PLAA. CaMKII-specific and CaM-specific inhibitors reduced cPLA2 and PKC activities, PGE2 release and osteoblast maturation markers in response to 1α,25(OH)2D3. Camk2a-silenced but not Camk2b-silenced osteoblasts showed comparable effects. Immunoprecipitation showed increased interaction of CaM and PLAA in response to 1α,25(OH)2D3. The results indicate that membrane actions of 1α,25(OH)2D3 via Pdia3 triggered the interaction between PLAA and CaM, leading to dissociation of CaM from caveolae, activation of CaMKII, and downstream PLA2 activation, and suggest that CaMKII plays a major role in membrane-mediated actions of 1α,25(OH)2D3.